# Spero Therapeutics, Inc.: Form 8-K, filed Sep 6, 2019

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K
- Filed: 2019-09-06
- Accepted by EDGAR: Sep 6, 2019, 08:45 ET
- Period: 2019-09-04
- Accession: 0001193125-19-239450
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312519239450/d795816d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312519239450/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312519239450/d795816d8k.htm

Filed Sep 6, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-239450. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
